AlphaFold predicted structure
MAP3K1 · Q13233

Mean pLDDT
58.8/ 100
Low
1,512 residues
Confidence breakdown
- Very high(≥ 90)18%
- Confident(70–90)26%
- Low(50–70)7%
- Very low(< 50)49%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
mitogen-activated protein kinase kinase kinase 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDifferences in sex development
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown46,XY sex reversal 6
46,XY partial gonadal dysgenesis
breast adenocarcinoma
breast carcinoma
ovarian cancer
prostate carcinoma
luminal A breast carcinoma
type 2 diabetes mellitus
breast cancer
Abnormality of the skeletal system
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Mitogen-activated protein kinase kinase kinase 1
Component of a protein kinase signal transduction cascade (PubMed:9808624). Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4 (PubMed:9808624). May phosphorylate the MAPK8/JNK1 kinase (PubMed:17761173). Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway (PubMed:9808624)
MAP3K1 · Q13233

Mean pLDDT
58.8/ 100
Low
1,512 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0